Amphastar Pharmaceuticals
AMPH
AMPH
95 hedge funds and large institutions have $168M invested in Amphastar Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
95
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.63M | |
| 2 | +$2.27M | |
| 3 | +$2.03M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.64M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$1.31M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$2.24M | |
| 3 | -$2.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.71M |
| 5 |
JG
Jefferies Group
New York
|
-$1.48M |